Saltar al contenido
Actividad y longevidadMetaanálisis de ensayos4 min read

Digital health tools modestly raise activity and fitness in people with chronic conditions

Colectivo editorial MoveVitals · Study published · Reading updated

Original paper:Benefits and Harms of Digital Health Interventions Promoting Physical Activity in People With Chronic Conditions: Systematic Review and Meta-Analysis. · Journal of medical Internet research · 2023 · Artículo original ↗

Idea principal

Across 130 randomised trials, digital health interventions increased objectively measured physical activity (standardized mean difference [SMD] 0.29, 95% CI 0.21-0.37 at the end of the intervention) and physical function (SMD 0.36, 95% CI 0.12-0.59) versus usual care or minimal intervention. Effects on activity shrank at follow-up (SMD 0.17), and non-serious adverse events were more common during the interventions.

Study design

Metaanálisis de ensayos

Reading basis

Published abstract

Reading focus

Design & applicability

Esta explicación editorial está disponible en inglés, chino simplificado y chino tradicional. Esta interfaz muestra la lectura en inglés.

Pregunta de investigación

Digital tools such as apps and trackers are widely proposed for managing chronic conditions, but their benefits and harms are unclear. The authors tested whether digital health interventions promoting physical activity help adults with common chronic conditions, and at what cost in side effects.

Población y método

Systematic review and meta-analysis of randomised controlled trials (PROSPERO CRD42020189028). MEDLINE, Embase, CINAHL and the Cochrane Central Register of Controlled Trials were searched from inception to October 2022. Trials were included if they used a digital component to promote physical activity in adults with at least 1 of depression or anxiety, ischemic heart disease or heart failure, chronic obstructive pulmonary disease, knee or hip osteoarthritis, hypertension, or type 2 diabetes. Primary outcomes were objectively measured physical activity and physical function (for example walk or step tests). A random effects model (restricted maximum likelihood) was used, with meta-regression, Cochrane Risk of Bias 2 and GRADE certainty ratings.

Resultados

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    From 14,078 hits, 130 randomised controlled trials were included.
  2. 2
    Objectively measured physical activity increased with digital interventions at the end of the intervention (SMD 0.29, 95% CI 0.21-0.37) and at follow-up (SMD 0.17, 95% CI 0.04-0.31).
  3. 3
    Physical function also improved, at the end of the intervention (SMD 0.36, 95% CI 0.12-0.59) and at follow-up (SMD 0.29, 95% CI 0.01-0.57).
  4. 4
    Depression, anxiety and health-related quality of life favoured digital interventions at the end of the intervention only; at follow-up only subjectively measured physical activity still favoured them.
  5. 5
    Non-serious adverse events were more frequent with digital interventions at the end of the intervention, but serious adverse events were not, and nothing differed at follow-up.

Límites e incertidumbre

  1. 1
    The trials cover six different condition groups and many kinds of digital tools, so one pooled effect hides large differences between interventions.
  2. 2
    The benefits shrank after the intervention ended, and the follow-up interval for physical function (0.01-0.57) nearly includes no effect.
  3. 3
    The authors say future studies need better reporting and head-to-head comparison of digital solutions, which means current evidence cannot say which tool works best.
  4. 4
    The abstract does not give certainty ratings or risk-of-bias results, and this reading is based on the abstract only.

Relevancia práctica

A digital programme can nudge people with conditions like hypertension, heart disease or type 2 diabetes to move more and improve walking or step test performance, though the gain is modest and fades after support ends. Check with your clinician before changing activity levels when you have a heart or lung condition.

Tus datos

Objectively measured activity in these trials usually means wearable or pedometer data, which is the same kind of step and activity data many people record. Compare weeks using the same device and wear pattern, and watch whether your gains hold after an app or programme ends.

Cómo interpretar la evidencia

Pooling trials can improve precision, but compare populations, controls, bias and uncertainty. Network rankings include indirect evidence and do not identify a universal best treatment.

Resumen estructurado de los autores English

El resumen original en inglés se reproduce con atribución bajo la licencia indicada. Es una fuente, no una interpretación de MoveVitals. El análisis preparado figura arriba; verifica los resultados importantes en la fuente.

Background

Digital health interventions for managing chronic conditions have great potential. However, the benefits and harms are still unclear.

Objective

This systematic review and meta-analysis aimed to investigate the benefits and harms of digital health interventions in promoting physical activity in people with chronic conditions.

Methods

We searched the MEDLINE, Embase, CINAHL, and Cochrane Central Register of Controlled Trials databases from inception to October 2022. Eligible randomized controlled trials were included if they used a digital component in physical activity promotion in adults with ≥1 of the following conditions: depression or anxiety, ischemic heart disease or heart failure, chronic obstructive pulmonary disease, knee or hip osteoarthritis, hypertension, or type 2 diabetes. The primary outcomes were objectively measured physical activity and physical function (eg, walk or step tests). We used a random effects model (restricted maximum likelihood) for meta-analyses and meta-regression analyses to assess the impact of study-level covariates. The risk of bias was assessed using the Cochrane Risk of Bias 2 tool, and the certainty of the evidence was assessed using the Grading of Recommendations Assessment, Development, and Evaluation.

Results

Of 14,078 hits, 130 randomized controlled trials were included. Compared with usual care or minimal intervention, digital health interventions increased objectively measured physical activity (end of intervention: standardized mean difference [SMD] 0.29, 95% CI 0.21-0.37; follow-up: SMD 0.17, 95% CI 0.04-0.31) and physical function (end of intervention: SMD 0.36, 95% CI 0.12-0.59; follow-up: SMD 0.29, 95% CI 0.01-0.57). The secondary outcomes also favored the digital health interventions for subjectively measured physical activity and physical function, depression, anxiety, and health-related quality of life at the end of the intervention but only subjectively measured physical activity at follow-up. The risk of nonserious adverse events, but not serious adverse events, was higher in the digital health interventions at the end of the intervention, but no difference was seen at follow-up.

Conclusions

Digital health interventions improved physical activity and physical function across various chronic conditions. Effects on depression, anxiety, and health-related quality of life were only observed at the end of the intervention. The risk of nonserious adverse events is present during the intervention, which should be addressed. Future studies should focus on better reporting, comparing the effects of different digital health solutions, and investigating how intervention effects are sustained beyond the end of the intervention.

Trial registration

PROSPERO CRD42020189028; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=189028.

Fuentes y atribución

Benefits and Harms of Digital Health Interventions Promoting Physical Activity in People With Chronic Conditions: Systematic Review and Meta-Analysis.

Zangger G, Bricca A, Liaghat B, Juhl CB, Mortensen SR, Andersen RM, Damsted C, Hamborg TG, Ried-Larsen M, Tang LH, Thygesen LC, Skou ST.

Journal of medical Internet research · 2023-07-06

DOI: 10.2196/46439 ↗PubMed · 37410534 ↗Europe PMC · Licencia registrada: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

Interpretación editorial de MoveVitals · contenido educativo · sin revisión clínica individual registrada

Fuentes verificadas 2026-11-01

Guías prácticas

Leer en contexto

·Metaanálisis observacional

7,000 steps a day linked to lower risk of death, heart disease and dementia than 2,000

Compared with 2000 steps a day, 7000 steps was associated with a hazard ratio of 0.53 (95% CI 0.46 to 0.60) for all-cause mortality across 14 studies, 0.75 (0.67 to 0.85) for cardiovascular disease and 0.62 (0.53 to 0.73) for dementia; cancer incidence was not significantly different (0.94, 0.87 to 1.01). Several outcomes rest on only two to four studies, and the certainty of evidence ranged from moderate to very low.

The Lancet Public Health

Explicaciones detalladasLeer estudio →
·Estudio de cohorte

Brief bursts of vigorous effort in daily life linked to lower mortality in non-exercisers

Among 25,241 UK Biobank adults who reported no leisure-time exercise, a median of 3 vigorous bouts of 1 or 2 minutes a day, picked up by a wrist accelerometer, was associated with a 38% to 40% lower risk of all-cause and cancer death and a 48% to 49% lower risk of cardiovascular death than no such bouts, over an average of 6.9 years and 852 deaths. This is an observational study using one week of wrist data and an algorithm to define vigorous effort, so it cannot show that adding such bursts causes the lower risk.

Nature Medicine

Explicaciones detalladasLeer estudio →
·Metaanálisis observacional

Steps and mortality: gains flatten near 6,000–8,000 (age 60+) and 8,000–10,000 (under 60)

Pooling 15 cohorts (47,471 adults, 3,013 deaths, median follow-up 7.1 years), the second, third and fourth quartiles of daily steps (medians 5,801, 7,842 and 10,901) had hazard ratios for death of 0.60, 0.55 and 0.47 against the lowest quartile (median 3,553). The curve flattened at about 6,000 to 8,000 steps a day for adults aged 60 and over and 8,000 to 10,000 for younger adults. The data are observational, from a single week of step counting, mostly with waist-worn research devices.

The Lancet Public Health

Explicaciones detalladasLeer estudio →
·Metaanálisis observacional

Accelerometers on 36,383 adults: any activity, even light, linked to lower mortality

In eight pooled cohorts (36,383 adults, mean age 62.6 years, 2,149 deaths over a median 5.8 years), the most active quarter by accelerometer-measured total activity had a mortality hazard ratio of 0.27 (95% CI 0.23 to 0.32) against the least active, and the most sedentary quarter had 2.63 (1.94 to 3.56). Light activity alone showed the same pattern, with 0.38 (0.28 to 0.51) in the top quarter. These are observational associations in adults aged 40 and over from the US and western Europe, so illness-driven inactivity and confounding cannot be excluded.

BMJ

Explicaciones detalladasLeer estudio →
Actividad y longevidad →